NCT00170690View on ClinicalTrials.gov

Preference Study With Elderly Patients Recurrent Ovarian Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions
Ovarian Cancer
Interventions
DRUG

Treosulfan

Treosulfan 600 mg/m² p.o. on daý 1-28, 57-84, etc

DRUG

Treosulfan

Treosulfan 7000 mg/m² i.v. on day 1, 29, 57 etc

Trial Locations (1)

13533

Charité Campus Virchow-Klinikum, Berlin

All Listed Sponsors
lead

North Eastern German Society of Gynaecological Oncology

OTHER

NCT00170690 - Preference Study With Elderly Patients Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter